Acrivastine

Active ingredient description

Acrivastine, a structural analog of triprolidine hydrochloride, exhibits H1-antihistaminic activity in isolated tissues, animals, and humans, and has sedative effects in humans. The propionic acid derivative of acrivastine is a metabolite in several animal species (as well as in man) and also exhibits H1-antihistaminic activity.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
R06AX18
Acrivastine
R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX18

Medicines

Acrivastine is the active ingredient of these drugs:

Drug
Countries
BENADRYL ALLERGY RELIEF

United Kingdom

SEMPREX

Netherlands

Acrivastine is also found within below combination drugs:

ACRISEU , BENADRYL ALLERGY RELIEF PLUS DECONGESTANT , DUACT , SEMPREX D

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
SEMPREX D Capsule
Structured Product Labeling (SPL)
US

Structural formula

Graphic representation of the active ingredient's molecular structure

Molecular mass: 348.438 g/mol

External identifiers

CAS Substance: 87848-99-5
DrugBank Drug: DB09488
KEGG Drug: D02760
RxNorm Ingredient: 19959
SNOMED-CT Concept: 391716003
Acrivastine (substance)
UNII Identifier: A20F9XAI7W
ACRIVASTINE
 
Next: Usage >